CO-TREATMENT WITH CDK4/6 AND CDK2 INHIBITORS TO SUPPRESS TUMOR ADAPTATION TO CDK2… Application WO-2021205363-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021